Commitment Letter Extension Agreement between Echo Therapeutics, Inc. and Platinum-Montaur Life Sciences, LLC

Summary

Echo Therapeutics, Inc. and Platinum-Montaur Life Sciences, LLC have agreed to extend the deadline for executing and delivering definitive documentation under their original Letter Agreement. The new deadline is August 31, 2012. This extension is formalized in this agreement, signed by both parties on August 24, 2012. No other terms of the original agreement are changed by this extension.

EX-10.4 8 ex10-4.htm ex10-4.htm
Exhibit 10.4
 
COMMITMENT LETTER EXTENSION AGREEMENT
 
Reference is hereby made to the Letter Agreement dated as of August 8, 2012 (the “Letter Agreement”) between Echo Therapeutics, Inc. (“Echo”) and Platinum-Montaur Life Sciences, LLC (“Platinum”).
 
Upon execution by each of Echo and Platinum below, the reference to the date of the execution and delivery of definitive documentation in the Section entitled “CLOSING” in the Letter Agreement shall be deemed amended to “August 31, 2012”.
 
IN WITNESS WHEREOF, the parties have entered into this Commitment Letter Extension Agreement as of August 24, 2012.

 
ECHO THERAPEUTICS, INC.
 
By:  /s/ Patrick Mooney
 
Name:  Patrick Mooney
 
Title:  CEO
 

 
PLATINUM-MONTAUR LIFE SCIENCES, LLC
 
By:  /s/ Michael M. Goldberg, M.D.
 
Name:  Michael M. Goldberg, M.D.
 
Title:  ________________